Both in Pharmaceuticals
Biomea Fusion vs Rallybio
Over the past year BMEA returned −38.8% and RLYB returned +286.4%; their daily moves had a correlation of 0.14.
BMEA −38.8% RLYB +286.4%Growth of $1, one year, split-adjusted
| Metric | BMEA | RLYB |
|---|---|---|
| Price | $1.26 | $17.22 |
| Market cap | $91.3M | $91.5M |
| Today | −2.33% | +1.00% |
| 1 month | −27.2% | +2.4% |
| 6 months | −4.5% | +114.2% |
| Year to date | +1.6% | +213.7% |
| 1 year | −40.0% | +291.4% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 2.0× |
| Price / sales | — | 141.6× |
| Net cash | $34.8M | $92.8M |
| Dividend yield | — | — |
| Volatility (60d) | 73.0% | 20.8% |
| Short % of float | 20.3% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).